Abstract
Background:
Among multiple factors that affect the etiology of polycystic ovary syndrome (PCOS), diet has an important contribution. Chronic oxidative stress has also been implicated in the development of PCOS. The present study is an attempt to evaluate dietary total antioxidant capacity (TAC) and its relationship with odds of PCOS in Iran.
Materials and Methods:
The study was carried out as a case-control study in hospital outpatient clinics, Tehran, Iran. Totally, 310 female participants with a history of PCOS and 602 age-matched controls took part in this study between June 2015 and December 2018. A reproducible and valid 168-item semi-quantitative food frequency inventory was utilized to determine the entire antioxidants of the usual diet in order to calculate dietary TAC. The relationship of dietary TAC with odds of PCOS were assessed adjusting for potential confounders through an estimation of two multivariable conditional regression models. The first tertile was presented as a reference category.
Results:
In a fully adjusted model, the highest tertile of dietary TAC was associated with a reduced odds of PCOS [odds ratio (OR): 0.81, 95% confidence interval (95% CI): 0.59, 0.96, P for trend: 0.038). In addition, PCOS odds decreased in the highest tertile of α-tocopherol intake (OR: 0.73, 95% CI: 0.56, 0.88, P for trend: 0.023). The adjusted ORs in the highest tertile of vitamin C, β-carotene and magnesium were 0.79 (95% CI: 0.83-0.97), 0.81 (95% CI: 0.67-0.98) and 0.91 (95% CI: 0.55-0.9 8) respectively, with a significant trend.
Conclusion:
Our results provide evidence that there was a relationship between high TAC diets and lower odds of PCOS.
Keywords: Antioxidant, Diet, Oxidative Stress, Polycystic Ovarian Syndrome
Introduction
Polycystic ovary syndrome (PCOS) is a common gynecological endocrinopathy that affects 8-13% of women in the reproductive age (1). Although, the cause of PCOS is still not fully understood, there are several possibilities. Main of them included: i. Hypothalamic/ pituitary dysregulation contributes to a rise in the ovarian androgen production and ii. Hyperandrogenism leads to insulin resistance that results to PCOS (2). Due to insulin resistance, hyperinsulinemia happens and speeds up the ovarian androgen production, which can lead to the PCOS occurrence (3, 4). Recent studies have demonstrated that oxidative stress contributes to the development of PCOS, infertility and hyperandrogenism (5, 6). Important factors that increase the oxidative stress in PCOS are insulin resistance and hyperglycemia (7).
Oxidative stress is clarified as a lack of balance among oxidants and antioxidants in the alive biological systems (8). The oxidative stress decrease is positively related to further matured oocytes in the infertile PCOS women (9). Oxidative stress causes widespread atherosclerosis lesions in the ovarian arteries (10, 11). Thus, the use of anti-oxidative agents has become an increasingly popular method in the PCOS management (12). Research works have shown that there is a relationship between PCOS and dietary intakes (13-15). The dietary antioxidants with a negative relationship with PCOS are vitamin C, vitamin E, selenium, zinc and beta-carotene (13). A recent study showed that plant-based dietary pattern is associated with lower odds ratio (OR) of PCOS and antioxidant-rich foods may protect the body against oxidative damage in these patients (14). Furthermore, adherence to an antioxidants-rich diet may be inversely associated with PCOS (15). There are emerging evidences that total antioxidant capacity (TAC) of dietary can be used as a measurement index that covers combined actions of dietary total antioxidants. This assay gives better predictions of dietary intake relation with chronic diseases (16). Studies demonstrate that higher dietary TAC is associated with lower weight and abdominal fat gain (17). Furthermore, higher dietary TAC is related to greater improvement in the heart disease risk factors and reduced risk of pancreatic cancer (18, 19).
Unfortunately, there is a shortage of data, especially on dietary TAC and PCOS relationship. Thus, this finding encouraged us to design a case-control study to examine the relationship of dietary TAC and the odds of PCOS.
Materials and Methods
Study design and population
All volunteers signed informed consent before the onset of the study. The Ethics Committee of Shahid Beheshti University of Medical Sciences approved the study (IR. SBMU.RETECH.REC.1398.750). The whole procedure was conducted as per the Helsinki Declaration of 1975, as revised in 2013 and the ethical standards of the responsible committee on human experimentation.
A total of 310 patients with a PCOS history between the ages of 20-35 years and 602 age-matched healthy volunteers participated in this case-control study. This study was performed in the various hospital endocrinology clinics of Tehran, Iran. Our case group inclusion criteria comprised women with a diagnosis or a history of PCOS. Based on the international Rotterdam Criteria 2003, PCOS patients diagnosed in the past three months had to have two out of three symptoms at least (20). They were diagnosed, follow of clinical or biochemical signs of hyper-androgenism, oligo-ovulation or anovulation and polycystic ovaries by ultrasonography. Also, control group was invited from age-matched referred patients to other clinics such as orthopedic, ear, nose, throat clinics or elective surgeries were referred to the same clinics that were not suffered of ongoing or previous PCOS. They had regular menstrual cycles (26-33 day cycles) without any ovulatory abnormalities, polycystic ovary and hyperandrogenism. The rest of the inclusion criteria for the control group were similar to the case group. On the third day of their menstrual cycle, endocrine hormones serum level and full pelvic ultrasound assessment were performed. All participants, cases and controls, were free of cardiovascular diseases, cancer, diabetes, renal disease and did not follow special diets.
Socio-demographic assessment
Age, smoking, first menarche age, literacy level, history of medication, supplementation and monthly family income were recorded from the pretested baseline questionnaire. Due to participants’ religious and cultural taboos, questions regarding alcohol and opium were omitted (21). Details of anthropometric and physical activity assessments have been reported previously (22).
Dietary assessment
The dietary data were collected through a valid semi-quantitative food frequency questionnaire (FFQ) (23). All participants were asked about their usual intakes over the past year, although in the case group we considered a last year before PCOS diagnosis. Nutrient Data Laboratory of United States Department of Agriculture (USDA) database was used to calculate dietary TAC for selected foods by the oxygen radical absorbance capacity method. Results were expressed as mmol of Trolox Equivalents (mmol TE/day) (24). Using residual method, dietary TAC was adjusted for total energy intake.
Statistical analysis
Data analysis was done in statistical package for the social sciences software (SPSS Inc., Chicago, IL, USA, version 20) (P<0.05). Kolmogorov-Smirnov test, histogram and Q-Q plot were used for normality of continuous variables. Dietary intake variables were not normally distributed. Therefore, transformations such as logarithm, square root, reciprocal, cube root, and square were done using parametric tests. Analysis of covariance (ANCOVA) adjusting for total energy was used to examine significant differences in antioxidant intakes. OR and 95% confidence intervals (CIs) were calculated by binary conditional logistic regression models to investigate the association of odds PCOS in each tertile dietary antioxidant variables. A tertile cut-off point was used to categorize dietary TAC, Vitamin C, α-tocopherol, zinc, β-carotene, lycopene selenium and magnesium were divided into the tertiles. The first tertile was presented as a reference category. The following variables were adjusted; body mass index (BMI), sex, age, physical activity, familiar history of PCOS, smoking and total energy intake.
Results
Final analysis was conducted on 303 PCOS cases (97.7% participation rate) and 588 controls (97.7%). Twenty-one participants were initially excluded given the log scales of total energy intake, which were either >3 or <3 standard deviation (SD) from the mean.
The mean ± SD for age was 29.1 ± 5.9 and 28.8 ± 6.2 in cases and controls represents the age-matched design. In comparison to the controls, BMI (33.7 ± 6.1 vs. 24.2 ± 4.9) and waist circumference (WC) (97.2 ± 8.2 vs. 80.1 ± 6.5) of the case group were higher along with the incidence of PCOS in their families (P<0.05). Mean metabolic equivalent (MET) (47.3 ± 5.9 hour/day vs. 58.1 ± 7.1 hour/day) and dietary fiber intake (13 ± 3.9 vs. 16 ± 4.1) were significantly lower in cases. In addition, the mean energy intake (3009 ± 709 vs. 2139 ± 605) in the cases was significantly higher in comparison with controls (P<0.05).
Table 1 lists the mean intakes of dietary antioxidant variables, both for cases and controls. Cases had lower dietary TAC, α-tocopherol, vitamin C and magnesium (P<0.005). No differences were found between cases and the control group as regards lycopene, zinc, and selenium.
Table 1.
| |||
---|---|---|---|
Dietary factors | PCOS women (n=303) | Control women (n=588) | P value* |
| |||
Dietary TAC(mmol/day) | 11.9 ± 3.9 | 14.1 ± 4.3 | 0.001 |
α-Tocopherol(mg/day) | 5.5 ± 1.9 | 7.3 ± 1.5 | 0.035 |
Vitamin C(mg/day) | 69.3 ± 32.3 | 84.1 ± 45.3 | <0.001 |
β-Carotene(μg/day) | 1691 ± 133 | 1727 ± 152 | 0.069 |
Lycopene (μg/day) | 1885 ± 178 | 1902 ± 196 | 0.122 |
Zinc (mg/day) | 11.9 ± 4.7 | 11.2 ± 3.9 | 0.234 |
Selenium(μg/day) | 52.3 ± 20.6 | 49.5 ± 22.3 | 0.321 |
Magnesium(mg/day) | 189.2 ± 44.9 | 227.8 ± 46.7 | <0.001 |
|
Data are presented as mean ± SD. *; Based on ANCOVA, PCOS; Polycystic ovary syndrome, and TAC; Total antioxidant capacity.
Associations of dietary antioxidant variables with odds of PCOS are shown in Table 2. There was a significant relationship between the dietary TAC with an odds ratio (OR) of PCOS in the base model (OR of the highest tertile compared to lowest one: 0.77, 95% CI: 0.49-0.91). After adjusting for BMI, WC, energy intake, dietary intake of fiber, familial history of PCOS and physical activity, the highest tertile of the dietary TAC score was associated with a reduced odds ratio of PCOS (OR: 0.81, 95% CI: 0.59-0.96). There was a significant linear decrease among the dietary TAC tertiles for the odds ratio of PCOS (P trend=0.038). There was an inverse relationship between the dietary intake of α-tocopherol and the odds of PCOS in both base and fully adjusted models. The multivariable OR (95% CI) for PCOS was 0.73 (0.56-0.88) in the highest tertiles of α-tocopherol, compared to the lowest tertile. The adjusted ORs in the highest tertile of vitamin C, β-carotene and magnesium were 0.79 (95% CI: 0.83-0.97), 0.81 (95% CI: 0.67- 0.98) and 0.91 (95% CI: 0.55-0.98) respectively, with a significant trend.
Table 2.
| ||||
---|---|---|---|---|
Dietary antioxidant variables | Tertiles of energy-adjusted intake | P for trend | ||
1st | 2nd | 3rd | ||
| ||||
Dietary TAC (mmol/day) | ||||
No. cases/No. controls | 131/196 | 93/196 | 79/196 | |
Base model† | 1.00(Ref.) | 0.87(0.53-1.07) | 0.77 (0.49-0.91) | 0.015 |
Full model‡ | 1.00 (Ref.) | 0.89 (0.48-1.03) | 0.81 (0.59-0.96) | 0.038 |
α-Tocopherol (mg/day) | ||||
No. cases/No. controls | 138/196 | 89/196 | 76/196 | |
Base model† | 1.00 (Ref.) | 0.73(0.53-1.03) | 0.69 (0.50-0.83) | <0.001 |
Full model‡ | 1.00 (Ref.) | 0.77 (1.23-1.02) | 0.73 (0.56-0.88) | 0.003 |
Vitamin C (mg/day) | ||||
No. cases/No. controls | 143/196 | 83/196 | 77/196 | |
Base model† | 1.00 (Ref.) | 0.75(0.43-1.08) | 0.74 (0.73-1.05) | 0.069 |
Full model‡ | 1.00 (Ref.) | 0.82 (0.83-1.03) | 0.79 (0.83-0.97) | 0.039 |
β-Carotene (μg/day) | ||||
No. cases/No. controls | 124/196 | 90/196 | 89/196 | |
Base model† | 1.00 (Ref.) | 0.80 (0.49-1.19) | 0.77(0.65-1.08) | 0.105 |
Full model‡ | 1.00 (Ref.) | 0.84 (0.60-1.18) | 0.81 (0.67-0.98) | 0.046 |
Lycopene (μg/day) | ||||
No. cases/No. controls | 122/196 | 93/196 | 88/196 | |
Base model† | 1.00 (Ref.) | 0.96 (0.69-1.22) | 0.99 (0.73-1.18) | 0.112 |
Full model‡ | 1.00 (Ref.) | 0.94(0.79-1.03) | 0.93 (0.63-1.07) | 0.059 |
Zinc (mg/day) | ||||
No. cases/No. controls | 100/196 | 88/196 | 115/196 | |
Base model† | 1.00 (Ref.) | 1.13 (0.71-1.29) | 0.99 (0.72-1.39) | 0.305 |
Full model‡ | 1.00 (Ref.) | 1.05 (0.83-1.15) | 1.02 (0.95-1.19) | 0.114 |
Selenium (μg/day) | ||||
No. cases/No. controls | 130/196 | 98/196 | 75/196 | |
Base model† | 1.00 (Ref.) | 1.09 (0.78-1.24) | 1.27 (0.62-1.33) | 0.286 |
Full model‡ | 1.00 (Ref.) | 1.11 (0.72-1.21) | 1.25 (0.65-1.39) | 0.273 |
Magnesium (mg/day) | ||||
No. cases/No. controls | 128/196 | 90/196 | 85/196 | |
Base model† | 1.00 (Ref.) | 0.91 (0.59-1.03) | 0.89 (0.50-1.04) | 0.062 |
Full model‡ | 1.00 (Ref.) | 0.93 (0.53-0.98) | 0.91 (0.55-0.98) | 0.047 |
|
Adjusted odds ratio (OR) estimates and 95% confidence intervals (CIs) for polycystic ovary syndrome (PCOS), according to the tertile of each dietary antioxidant variables. *; A conditional logistic regression model, † ; Adjusted for age (5-year categories), ‡ ; Adjusted for age (5-year categories), body mass index (BMI, Kg/m2), waist circumference (WC, cm) intake (Kcal/d), dietary intake of fiber (g/d), familial history of PCOS (yes/no) and physical activity (MET/h/d).
Discussion
To be best of our knowledge, the association of dietary TAC with PCOS was assessed for the first time in a developing country in the present study. Higher intake of dietary TAC, α-tocopherol, vitamin C, β-carotene and magnesium were inversely associated with lower odds of PCOS, even after adjusting for confounding factors. Intake of the α-tocopherol, vitamin C and β-carotene were significantly associated with reducing the odds of PCOS. Our data are consistent with Shahrokhi and Naeini (13) study that demonstrated relationship between the higher intakes of vitamin C, vitamin E, and β-carotene and the reduced odds of PCOS. Barrea et al. (25) reported a relationship between the Mediterranean diet (rich in antioxidants) and decreased odds of PCOS that consistent with our findings these data show a relationship between a diet high in the TAC and decreased odds of PCOS. Similarly with the current study, we previously found a significant negative association between adherence to the antioxidant nutrient pattern and odds of PCOS (15). Furthermore, clinical trials demonstrated the beneficial effects of dietary antioxidants on the PCOS management (26). It was interesting that, Shahrokhi and Naeini (13) and present study are contradictory about the relationship of the zinc and selenium intakes with PCOS. In the present study, we found no significant association between zinc and selenium with the odds of PCOS, while Shahrokhi and Naeini (13) showed dietary selenium and zinc were inversely associated with PCOS at a significant level.
As to the important role of diet in the chronic diseases, examine the general dietary antioxidant intake seems essential, particularly, the different antioxidants proportion of diet in combination with synergistic effects that prevent diseases via several mechanisms. Dietary TAC considers the synergistic interactions of antioxidant nutrients and can be used to assess the relationship between dietary intake and several chronic disorders. Verit et al. (27) found that TAC was the most important prediction element to PCOS. Kanafchian et al. (28) concluded TAC is decreased in the PCOS patients, which may be due to increased oxidative stress. Enechukwu et al. (29) showed that decreased TAC correlates with the cause of PCOS in these patients. However, Ghowsi et al. (30) and Shahrokhi and Naeini (13) found that there were not any significant differences in the serum TAC in the PCOS patients and the healthy control group.
An imbalance between the antioxidant and free radical production in the ovaries can cause negative effects on the oocyte quality, productivity, development, and growth of the placenta (31, 32). Lowered oxidative stress is related to better prognosis of PCOS (33). PCOS can lead to a decrease in the quality of life, especially if it is accompanied by chronic diseases like type 2 diabetes mellitus, obesity, dyslipidemia, hypertension, heart disease in which oxidative stress may intensify complications of these diseases (34). Antioxidants have a relationship with apoptosis in the ovarian tissue via different mechanisms. These are connected with proper growth and action of interstitial cells (35). Antioxidants, which impede or restrict, the harmful results of oxygen radicals have a vital role in the reproductive system functional and fertility process in the female (36). The dietary approaches to stop hypertension (DASH) diet is featured with using of the high amount of fruit, vegetables and legumes (37). A review study showed that the DASH diet and lower levels of oxidative stress biomarkers are related to each other (38). Obese women with the DASH eating plan are at the risk of the improvement of insulin resistance and inflammatory factors (37). Also, a dietary trigger like glucose can induce oxidative stress and cause an inflammatory response even without excess of adiposity in the PCOS patients. Based on a previous study, Mediterranean-inspired low glycemic load anti-inflammatory diet can improve hormones, body composition, and menstrual cyclicity, metabolic status, and inflammatory factors (39).
Our study has several limitations. Although, the validity and reproducibility of FFQ among Iranians has been well supported, our data may suffer from measurement error. However, we excluded participants that under/over reported their energy intakes. The nature of case-control design with its inherent biases would not allow establishing causation. Since cases were chosen out of a newly-diagnosed PCOS patients, there is less concern about recall bias. Since control group were recruited from the same hospital, similar socioeconomic status, a great element in the developing countries that influence nutritional status/intake can be greatly controlled. In order to control selection bias, we selected our control group of the same clinical center because their participation rate were higher. Residual confounding may not be completely ruled out because of imprecise measurements of covariates. However, there is a small risk that measurement errors in confounders were extreme since the crude and multivariable results were basically similar. Moreover, studies have reported that clinic PCOS patients tend to be more overweight than community PCOS patients, which can significantly affect the severity of PCOS (40). Similarly, the women in our study were more severely affected. We did not match cases and controls for BMI due to overmatching as it could narrow the exposure range.
One of the strengths present study was the high participation rate. When dietary information is obtained at onset of disease, it may not always reflect a typical eating pattern, thus cases may have altered their diet according to their disease symptoms. Therefore, to reduce the possibility of changing the habitual dietary intake, cases were included in the study 3 months prior to the interview. Controls were also free of any major risk factors for PCOS. Another strength was the use of FFQ along with a detailed assessment with adjustment for potential confounders. Compared to a single 24-h dietary recall, the FFQ allowed us to collect rarely consumed food items as well as seasonal variations.
Conclusion
Our results indicated that a high TAC diet plays a role in lowering the odds ratio of developing PCOS, although large prospective studies are needed to expand on these findings.
Acknowledgements
The authors thank all the volunteers who participated in this study. We also appreciate the “Student Research Committee” and “Research and Technology Chancellor” in Shahid Beheshti University of Medical Sciences for their financial support of this study. This study is related to the project NO 1398/10505 from the Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran. None of the authors had any conflicts of interest to report.
Authors’ Contributions
G.E., N.S.; Conceptualized and designed the study and wrote the manuscript. G.E., N.S., S.R., M.N.; Analyzed data, interpreted the data, provided professional comments. N.S., S.R., M.N., S.N.M.; Collected data. S.M., S.R., M.N., S.N.M.; Critically revised the manuscript for intellectual content and data accuracy. G.E.; Had responsibility for final content. All of the authors read and approved the final manuscript.
References
- 1.Kakoly NS, Earnest A, Teede HJ, Moran LJ, Joham AE. The impact of obesity on the incidence of type 2 diabetes among women with polycystic ovary syndrome. Diabetes Care. 2019;42(4):560–567. doi: 10.2337/dc18-1738. [DOI] [PubMed] [Google Scholar]
- 2.Nadjarzadeh A, Dehghani Firouzabadi R, Vaziri N, Daneshbodi H, Lotfi MH, Mozaffari-Khosravi H. The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: a randomized clinical trial. Iran J Reprod Med. 2013;11(8):665–672. [PMC free article] [PubMed] [Google Scholar]
- 3.Barbieri RL, Makris A, Randall RW, Daniels G, Kistner RW, Ryan KJ. Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J Clin Endocrinol Metab. 1986;62(5):904–910. doi: 10.1210/jcem-62-5-904. [DOI] [PubMed] [Google Scholar]
- 4.Cara JF, Rosenfield RL. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology. 1988;123(2):733–739. doi: 10.1210/endo-123-2-733. [DOI] [PubMed] [Google Scholar]
- 5.Var A, Kuşcu NK, Koyuncu F, Uyanik BS, Onur E, Yildirim Y, et al. Atherogenic profile in preeclampsia. Arch Gynecol Obstet. 2003;268(1):45–47. doi: 10.1007/s00404-002-0317-4. [DOI] [PubMed] [Google Scholar]
- 6.Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril. 2003;80(1):123–127. doi: 10.1016/s0015-0282(03)00571-5. [DOI] [PubMed] [Google Scholar]
- 7.Zuo T, Zhu M, Xu W. Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev. 2016;2016:8589318–8589318. doi: 10.1155/2016/8589318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Sabuncu T, Vural H, Harma M, Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem. 2001;34(5):407–413. doi: 10.1016/s0009-9120(01)00245-4. [DOI] [PubMed] [Google Scholar]
- 9.Combelles CM, Gupta S, Agarwal A. Could oxidative stress influence the in-vitro maturation of oocytes? Reprod Biomed Online. 2009;18(6):864–880. doi: 10.1016/s1472-6483(10)60038-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2013;6:1–13. doi: 10.2147/CLEP.S37559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R, et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565–4592. doi: 10.1210/jc.2013-2350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Aquino CI, Nori SL. Complementary therapy in polycystic ovary syndrome. Transl Med UniSa. 2014;9:56–65. [PMC free article] [PubMed] [Google Scholar]
- 13.Shahrokhi SA, Naeini AA. The association between dietary antioxidants, oxidative stress markers, abdominal obesity and polycystic ovary syndrome: a case control study. J Obstet Gynaecol. 2020;40(1):77–82. doi: 10.1080/01443615.2019.1603215. [DOI] [PubMed] [Google Scholar]
- 14.Noormohammadi M, Eslamian G, Malek S, Shoaibinobarian N, Mirmohammadali SN. The association between fertility diet score and polycystic ovary syndrome: a case-control study. Health Care Women Int. 2022;43(1-3):70–84. doi: 10.1080/07399332.2021.1886298. [DOI] [PubMed] [Google Scholar]
- 15.Eslamian G, Hekmatdoost A. Nutrient patterns and risk of polycystic ovary syndrome. J Reprod Infertil. 2019;20(3):161–168. [PMC free article] [PubMed] [Google Scholar]
- 16.Puchau B, Zulet MA, de Echávarri AG, Hermsdorff HH, Martínez JA. Dietary total antioxidant capacity: a novel indicator of diet quality in healthy young adults. J Am Coll Nutr. 2009;28(6):648–656. doi: 10.1080/07315724.2009.10719797. [DOI] [PubMed] [Google Scholar]
- 17.Besagil PS, Calapkorur S, Sahin H. Determination of the relationship between total antioxidant capacity and dietary antioxidant intake in obese patients. Niger J Clin Pract. 2020;23:481–488. doi: 10.4103/njcp.njcp_212_19. [DOI] [PubMed] [Google Scholar]
- 18.Kim K, Vance TM, Chun OK. Greater total antioxidant capacity from diet and supplements is associated with a less atherogenic blood profile in U.S.adults. Nutrients. 2016;8(1):15–15. doi: 10.3390/nu8010015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Zhong GC, Pu JY, Wu YL, Yi ZJ, Wan L, Wang K, et al. Total antioxidant capacity and pancreatic cancer incidence and mortality in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2020;29(5):1019–1028. doi: 10.1158/1055-9965.EPI-19-1511. [DOI] [PubMed] [Google Scholar]
- 20.Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS) Hum Reprod. 2004;19(1):41–47. doi: 10.1093/humrep/deh098. [DOI] [PubMed] [Google Scholar]
- 21.Safari A, Shariff ZM, Kandiah M, Rashidkhani B, Fereidooni F. Dietary patterns and risk of colorectal cancer in Tehran province: a case-control study. BMC Public Health. 2013;13:222–222. doi: 10.1186/1471-2458-13-222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Eslamian G, Baghestani AR, Eghtesad S, Hekmatdoost A. Dietary carbohydrate composition is associated with polycystic ovary syndrome: a case-control study. J Hum Nutr Diet. 2017;30(1):90–97. doi: 10.1111/jhn.12388. [DOI] [PubMed] [Google Scholar]
- 23.Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654–662. doi: 10.1017/S1368980009991698. [DOI] [PubMed] [Google Scholar]
- 24.Haytowitz DB, Bhagwat S. USDA database for the oxygen radical absorbance capacity (ORAC) of selected foods, Release 2.USDA.Beltsbille. Beltsbille; 2010. [Google Scholar]
- 25.Barrea L, Arnone A, Annunziata G, Muscogiuri G, Laudisio D, Salzano C, et al. Adherence to the mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS) Nutrients. 2019;11(10):2278–2278. doi: 10.3390/nu11102278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Amini L, Tehranian N, Movahedin M, Ramezani Tehrani F, Ziaee S. Antioxidants and management of polycystic ovary syndrome in Iran: a systematic review of clinical trials. Iran J Reprod Med. 2015;13(1):1–8. [PMC free article] [PubMed] [Google Scholar]
- 27.Verit FF, Erel O, Kocyigit A. Association of increased total antioxidant capacity and anovulation in nonobese infertile patients with clomiphene citrate-resistant polycystic ovary syndrome. Fertil Steril. 2007;88(2):418–424. doi: 10.1016/j.fertnstert.2006.11.172. [DOI] [PubMed] [Google Scholar]
- 28.Kanafchian M, Esmaeilzadeh S, Mahjoub S, Rahsepar M, Ghasemi M. Status of serum copper, magnesium, and total antioxidant capacity in patients with polycystic ovary syndrome. Biol Trace Elem Res. 2020;193(1):111–117. doi: 10.1007/s12011-019-01705-7. [DOI] [PubMed] [Google Scholar]
- 29.Enechukwu CI, Onuegbu AJ, Olisekodiaka MJ, Eleje GU, Ikechebelu JI, Ugboaja JO, et al. Oxidative stress markers and lipid profiles of patients with polycystic ovary syndrome in a Nigerian tertiary hospital. Obstet Gynecol Sci. 2019;62(5):335–343. doi: 10.5468/ogs.2019.62.5.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ghowsi M, Khazali H, Sisakhtnezhad S. The effect of resveratrol on oxidative stress in the liver and serum of a rat model of polycystic ovary syndrome: An experimental study. Int J Reprod Biomed. 2018;16(3):149–158. [PMC free article] [PubMed] [Google Scholar]
- 31.Yalçınkaya E, Cakıroğlu Y, Doğer E, Budak O, Cekmen M, Calışkan E. Effect of follicular fluid NO, MDA and GSH levels on in vitro fertilization outcomes. J Turk Ger Gynecol Assoc. 2013;14(3):136–141. doi: 10.5152/jtgga.2013.53323. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Nuñez-Calonge R, Cortés S, Gutierrez Gonzalez LM, Kireev R, Vara E, Ortega L, et al. Oxidative stress in follicular fluid of young women with low response compared with fertile oocyte donors. Reprod Biomed Online. 2016;32(4):446–456. doi: 10.1016/j.rbmo.2015.12.010. [DOI] [PubMed] [Google Scholar]
- 33.Ressler IB, Grayson BE, Ulrich-Lai YM, Seeley RJ. Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model. Am J Physiol Endocrinol Metab. 2015;308(12):E1076–1084. doi: 10.1152/ajpendo.00182.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Orio F, Muscogiuri G, Nese C, Palomba S, Savastano S, Tafuri D, et al. Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2016;207:214–219. doi: 10.1016/j.ejogrb.2016.08.026. [DOI] [PubMed] [Google Scholar]
- 35.Teixeira Filho FL, Baracat EC, Lee TH, Suh CS, Matsui M, Chang RJ, et al. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(3):1337–1344. doi: 10.1210/jcem.87.3.8316. [DOI] [PubMed] [Google Scholar]
- 36.Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005;3:28–28. doi: 10.1186/1477-7827-3-28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Asemi Z, Esmaillzadeh A. DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial. Horm Metab Res. 2015;47(3):232–238. doi: 10.1055/s-0034-1376990. [DOI] [PubMed] [Google Scholar]
- 38.Pirouzeh R, Heidarzadeh-Esfahani N, Morvaridzadeh M, Izadi A, Yosaee S, Potter E, et al. Effect of DASH diet on oxidative stress parameters: a systematic review and meta-analysis of randomized clinical trials. Diabetes Metab Syndr. 2020;14(6):2131–2138. doi: 10.1016/j.dsx.2020.10.031. [DOI] [PubMed] [Google Scholar]
- 39.Salama AA, Amine EK, Salem HA, Abd El Fattah NK. Antiinflammatory dietary combo in overweight and obese women with polycystic ovary syndrome. N Am J Med Sci. 2015;7(7):310–316. doi: 10.4103/1947-2714.161246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Ezeh U, Yildiz BO, Azziz R. Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98(6):E1088–1096. doi: 10.1210/jc.2013-1295. [DOI] [PMC free article] [PubMed] [Google Scholar]